PRF Technologies (PRFX) Retained Earnings (2019 - 2026)
PRF Technologies' (PRFX) quarterly Retained Earnings came in at $80.0 million in Q2 2026, up 4636.91% on a YoY basis from $1.7 million in Q2 2025, and up 14.5% quarter-over-quarter from $69.8 million in Q4 2025.
Powered by 
Analysis
PRF Technologies (PRFX) Retained Earnings (2019 - 2026) Analysis & Trends
PRF Technologies (PRFX) has reported Retained Earnings for 8 consecutive years, with $80.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Retained Earnings rose 4636.91% year-over-year to $80.0 million; the trailing twelve-month figure through Jun 2026 stood at $80.0 million (up 4636.91% YoY), and the FY2025 full-year result was $69.8 million, up 223.7% from the prior year.
- Retained Earnings advanced to $80.0 million in Q2 2026 per PRFX's latest filing, from $69.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at $80.0 million in Q2 2026 and bottomed at -$56.5 million in Q4 2024.
- Historically, Retained Earnings has averaged $35.7 million across 5 years, with a median of $43.5 million in 2022.
- The sharpest annual moves came in 2024 and 2026: Retained Earnings tumbled 171163.64% in 2024, then surged 4636.91% in 2026.
- Over 5 years, Retained Earnings stood at $43.4 million in 2022, then plunged by 99.92% to $33000.0 in 2023, then plunged by 171163.64% to -$56.5 million in 2024, then soared by 223.7% to $69.8 million in 2025, then gained by 14.5% to $80.0 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $80.0 million, $69.8 million, and $1.7 million for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 28.26 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 18.56 Bn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 3.76 Bn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 545.58 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | -10.83 Bn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 620.25 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | -2.48 Bn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 703.65 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | -227.25 Mn |
| 10 | PRF Technologies | 622,054.07 | -10.31 Mn | - | 79.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.96 Mn |
| Dec 31, 2025 | 69.83 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Dec 31, 2024 | -56.45 Mn |
| Jun 30, 2024 | 52.35 Mn |
| Mar 31, 2024 | 49.06 Mn |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 45.48 Mn |
| Jun 30, 2023 | 43.89 Mn |
| Mar 31, 2023 | 43.63 Mn |
| Dec 31, 2022 | 43.45 Mn |
| Sep 30, 2022 | 42.68 Mn |
| Jun 30, 2022 | 42.35 Mn |
| Mar 31, 2022 | 42.03 Mn |
| Dec 31, 2021 | 41.72 Mn |
| Sep 30, 2021 | 41.37 Mn |
| Jun 30, 2021 | 39.14 Mn |
| Mar 31, 2021 | 38.83 Mn |
| Dec 31, 2020 | 33.02 Mn |
| Jun 30, 2020 | 222,000.00 |
API Access
PRF Technologies Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=PRFX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "PRFX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=PRFX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();